Invasive cervical cancer remains the second most common malignancy affecting women worldwide. Early-stage disease may be asymptomatic. Advances in imaging techniques have improved selection of the appropriate treatment modality. Treatment options vary for each stage. Cone biopsy is sufficient for treatment...
Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The european society of gynaecological oncology/european society for radiotherapy and oncology/european society of pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Ca...
microinvasive cancermicroinvasive squamous carcinomaSummary This chapter contains sections titled: Introduction Microinvasive Squamous Cell Carcinoma of the Cervix Diagnosis of Microinvasive Cancer Treatment Options for Microinvasive Squamous Carcinoma Microinvasive Adenocarcinoma of the Cervix Treatment of Micro...
as well as possible neoadjuvant chemotherapy in larger-sized lesions, may broaden the feasibility of fertility-sparing options for more patients.183Nonetheless, women who desire fertility-preserving surgery for early cervical cancer need to be carefully selected and adequately counseled regarding risk of...
HPV DNA test—a lab test that detects the most common types of HPV that are likely to lead to cervical cancer If a woman has an abnormal PAP test result, additional tests are needed to confirm the diagnosis, determine the extent of the cancer, and direct treatment options. ...
The treatment options available to women who have this condition depend on what the cause of the friable cervix is. Large tumors and cysts that are damaging the cervix have to be removed by a surgical operation. If there is cancer present, the cervix and uterus might also have to be taken...
CIN is a term describing abnormal changes in the cells of the cervix, ranging from CIN1 to CIN3, which is precancerous. Colposcopy is used to visualise the cervix. Three adjunctive colposcopy technologies for examination of the cervix have been included in this assessment: Dynamic Spectral ...
Agensys a biotechnology company, engages in the research and development of therapeutic human monoclonal antibodies and antibody drug conjugates for the treatment of cancer. It offers products to treat various tumors, as well as prostate, pancreatic, and bladder cancers. The company, formerly known as...
the potential to influence HCP perspectives and as such may impact the treatment options, information and support made available to LGBTQ people with cancer and their partners (Ussher et al.,2013). It is therefore necessary to consider the extent to which such frameworks can address the sexual ...
In this review, we did not find strong evidence to recommend routine SBRT as a primary treatment for cervico-uterine cancers, i.e. as a replacement for BCT; in highly selected cases it might be considered useful as salvage therapy for relapsed cervix cancer. Conclusion The existing data to ...